RT Journal Article
SR Electronic
T1 Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 240
DO 10.1186/s40425-019-0706-x
VO 7
IS 1
A1 Bilusic, Marijo
A1 Heery, Christopher R.
A1 Collins, Julie M.
A1 Donahue, Renee N.
A1 Palena, Claudia
A1 Madan, Ravi A.
A1 Karzai, Fatima
A1 Marté, Jennifer L.
A1 Strauss, Julius
A1 Gatti-Mays, Margaret E.
A1 Schlom, Jeffrey
A1 Gulley, James L.
YR 2019
UL http://jitc.bmj.com/content/7/1/240.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.